There are more coronavirus vaccines that have been deployed all over the world, and these remain surrounded by controversy due to their potential side effects that can be harmful to some.
Reuters press agency just revealed that Taiwan just rejected an application for the emergency use of UBI Pharma’s (6562.TWO) COVID-19 vaccine candidate. This is what the government said on Monday, though the president said she would get a separate domestic shot in a show of support for the scheme.
Developing a local vaccine has been an important goal
Reuters also noted that Taiwan had ordered millions of Moderna (MRNA.O) and AstraZeneca (AZN.L) shots, but, on the other hand, developing a local vaccine has been a major goal and it is due next week to start administering its first domestic vaccine, made by Medigen Vaccine Biologics (6547.TWO).
It’s been also reported that the health ministry thought it would be a great idea to explain the rejection of the request for emergency use authorisation (EUA).
He said that the antibodies triggered by UBI’s candidate did not match up with those of the AstraZeneca vaccine. But, UBI still planned Phase III trials in India.
The same press agency noted that the Health Minister Chen Shih-Chung expressed regret that the EUA had not been granted.
“We still have to follow certain standards,” he told reporters.
Delta is coronavirus on steroids
The Delta Covid variant is ruling all the other strains across the globe these days. It’s been already revealed that the Delta variant is the most dangerous one so far, according to more expert opinions across the globe.
This highly transmissible Delta variant of the coronavirus which is causing the disease Covid 19 is now lingering in 124 countries, and it will soon become the dominant strain globally in the upcoming months.
It’s been just revealed by CNBC that the World Health Organization officials said they are still trying to understand the delta variant.